HappiLong

Tadalafil

Erectile dysfunction in adult males.

Adult Recommended dose: 10 mg, may be increased to 20 mg if 10 mg does not produce adequate effect. Taken at least 30 min prior to sexual activity. Max dose frequency: Once daily.

May be taken with or without food.

Hypersensitivity. Concomitant use w/ organic nitrates. Men w/ cardiac disease for whom sexual activity is inadvisable. Patients w/ MI w/in the last 90 days; unstable angina or angina occurring during sexual intercourse; NYHA class 2 or greater heart failure in the last 6 mth; uncontrolled arrhythmias, hypotension (<90/50 mmHg), or uncontrolled HTN; stroke w/in the last 6 mth. Patients who have loss of vision in 1 eye caused by non-arteritic anterior ischaemic optic neuropathy (NAION).

Determine potential underlying causes of erectile dysfunction before considering pharmacological treatment. Consider CV status of patients before treatment initiation. Patients w/ pre-existing CV risk factors; anatomical deformation of the penis (eg, angulation, cavernosal fibrosis, Peyronie's disease) or risk factors for priapism (eg, sickle cell anaemia, multiple myeloma, leukaemia); rare hereditary problems of galactose intolerance, Lapp lactase deficiency or glucose-galactose malabsorption. Discontinue in case of sudden visual defect. Not recommended w/ doxazosin. Caution when co-administered w/ potent CYP3A4 inhibitors (ritonavir, saquinavir, ketoconazole, itraconazole, erythromycin). Do not co-administer w/ other PDE5 inhibitors or other treatments for erectile dysfunction. Not recommended in patients w/ severe renal & hepatic impairment. Not indicated in women. No relevant use in paed population.

Drugs for Erectile Dysfunction & Ejaculatory Disorders

G04BE08 - tadalafil ; Belongs to the class of drugs used in erectile dysfunction.

P₁S₁S₃